Research Article
Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy
Table 2
Cancer cases among HIV-infected persons.
| | Cancer site | Female
(%) | Male
(%) | Total
(%) |
| | AIDS-defining cancer | | | | | Kaposi’s sarcoma | 4 (2.6) | 135 (13.8) | 139 (12.3) | | Non-Hodgkin’s lymphoma | 26 (17.1) | 156 (16.0) | 182 (16.1) | | Cervix | 5 (3.3) | — | 5 (0.4) | | Non-AIDS-defining cancer | | | | | Oropharynx | 1 (0.7) | 21 (2.2) | 22 (2.0) | | Colon/rectum | 6 (4.0) | 56 (5.7) | 62 (5.5) | | Liver | 3 (2.0) | 13 (1.3) | 16 (1.4) | | Pancreas | 2 (1.3) | 13 (1.3) | 15 (1.3) | | Anus | 14 (9.2) | 122 (12.5) | 136 (12.0) | | Larynx | 0 | 12 (1.2) | 12 (1.1) | | Lung, bronchus | 12 (7.9) | 51 (5.2) | 63 (5.6) | | Skin excluding melanoma, basal, and squamous cell | 2 (1.3) | 32 (3.3) | 34 (3.0) | | Breast | 40 (26.3) | — | 40 (3.5) | | Bladder | 4 (2.6) | 24 (2.4) | 28 (2.5) | | Prostate | — | 119 (12.2) | 119 (10.5) | | Hodgkin’s lymphoma | 4 (2.6) | 53 (5.4) | 57 (5.0) | | Other | 29 (19.1) | 171 (17.5) | 200 (17.7) | | Total | 152 | 978 | 1130 |
|
|
